key: cord-1054475-cuw1aowj
authors: Wang, Kun; Zhang, Xin; Sun, Jiaxing; Ye, Jia; Wang, Feilong; Hua, Jing; Zhang, Huayu; Shi, Ting; Li, Qiang; Wu, Xiaodong
title: Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens among Adult Inpatients with COVID-19
date: 2020-06-20
journal: Chest
DOI: 10.1016/j.chest.2020.06.015
sha: 4f8428110f020c126316feb0f17d37b8508ab510
doc_id: 1054475
cord_uid: cuw1aowj

Abstract Background The viral shedding duration of SARS-CoV-2 has not been fully defined. Consecutive detection of SARS-CoV-2 RNA from respiratory tract specimens is essential for determining duration of virus shedding and providing evidence to optimize the clinical management of COVID-19. Research Question What are the shedding durations of SARS-CoV-2 RNA in upper and lower respiratory tract specimens respectively? What are their associated risk factors? Study Design and Methods: A total of 68 patients with COVID-19 admitted to Wuhan Taikang Tongji Hospital and Huoshenshan Hospital from February 10, 2020 to March 20, 2020 were recruited. Consecutive SARS-CoV-2 RNA detection from paired specimens of nasopharyngeal swab (NPS) and sputum were carried out. The clinical characteristics of patients were recorded for further analysis. Results SARS-CoV-2 RNA was detected from NPS in 48 (70.6%) patients, and from sputum specimens in 30 (44.1%) patients. The median duration of viral shedding from sputum specimens (34 days, IQR 24-40 days) was significantly longer than from NPS (19 days, IQR 14-25 days; P<0.001). Elderly age was an independent factor associated with prolonged virus shedding time of SARS-CoV-2 (HR 1.71, 1.01-2.93). It was noteworthy that in 9 patients the viral RNA was detected in sputum after NPS turned negative. Chronic lung disease and steroids were associated with virus detection in sputum, and diabetes mellitus was associated with virus detection in both NPS and sputum. Interpretation These findings may impact a test based clearance discharge criteria given patients with COVID-19 may shed virus longer in their lower respiratory tracts, with potential implication for prolonged transmission risk. In addition, more attention should be given to elderly patients who might have prolonged viral shedding duration.

Since December 2019, an outbreak of pneumonia started in Wuhan, China and 2 gradually spread around world. The pathogen has been identified as a novel 3 enveloped RNA beta-coronavirus named severe acute respiratory syndrome 4 coronavirus 2 (SARS-CoV-2), which has a phylogenetic similarity to SARS-CoV, and 5 has now been designated coronavirus disease 2019 by the WHO 1 . The 6 clinical manifestations of COVID-19 vary diversely from asymptomatic infection to 7 mild upper respiratory tract infection and even acute respiratory distress syndrome [1] [2] [3] [4] . 8

Even though COVID-19 in China has been temporarily contained through proactive 9 public health interventions including early detection and quarantine, it has rapidly 10 spread to cause a pandemic around the world. Up to 9 June, 2020, the global number 11 of laboratory-confirmed cases had been more than 7.0 million, highlighting that 12 COVID-19 poses a substantial threat to the international health. 13

Characterizing the infectivity of SARS-CoV-2 is important for disease control and 14 prevention. The duration of viral shedding, which has been recognized as a proxy 15 measure of the infectious period for other respiratory viruses 5,6 , is a current 16 consideration with SARS-CoV-2. Hence, it is of urgent need to elucidate the viral 17

shedding duration among patients with COVID-19 to optimize public health 18 management policy. 19 COVID-19 is an infectious disease that transmitted mainly through respiratory tract. 20

Therefore, consecutive detection of SARS-CoV-2 RNA from respiratory tract 21 specimens using real-time reverse transcription-polymerase chain reaction (rRT-PCR) 22

with approximate sensitivity of 70% and specificity of 95% 7 , is crucial for defining 23 virus shedding duration and may impact clinical decisions on a patient's discharge 24 from the hospital and whether isolation and surveillance is required depending on 25 infection control recommendations in a particular country. Nasopharyngeal swab 26

(NPS) has been widely used for diagnosis and dynamic observation of patients on account of its ease of acquisition. Two consecutive negative detections of 28 SARS-CoV-2 RNA in NPS specimens have been recognized as criterion for discharge 1 from hospital or release from quarantine [8] [9] [10] [11] . Nevertheless, one limitation of NPS is 2 the possibility of false negative results, raising the concern that persistence of viral 3 shedding might be present in lower respiratory tract 12 . 4

Sputum has been reported to be more sensitive than NPS in SARS-CoV-2 RNA 5 detection since SARS-CoV-2 mainly bind with ACE2 receptor of lower respiratory 6 tract 13-15 . However, the use of sputum specimen in clinical practice is quite limited 7 because only a proportion of patients with COVID-19 produce sputum spontaneously. 8

Induced sputum is a convenient option to get lower respiratory tract samples and Han 9 et.al. proposed in a case report that SARS-CoV-2 RNA could be detected more readily 10 in sputum specimen than in upper respiratory tract specimen 10 . The risk of medical 11 staff exposure to COVID-19 is lower with sputum induction than with 12 bronchoalveolar lavage methods, although bronchoalveolar lavage fluid exhibited the 13 higher positive rate compared with the nasal and pharyngeal swabs samples 13, 16 . 14 However, the SARS-CoV-2 detection yield and distinct virus shedding duration 15 between sputum and NPS remained unclear. 16

We conducted a prospective cohort study of 68 hospitalized patients with 17 laboratory-confirmed COVID-19, by consecutively monitoring SARS-CoV-2 RNA 18 detection from paired specimens of NPS and sputum aiming to identify viral shedding 19 duration in upper and lower respiratory tract specimens respectively and to investigate 20 possible factors associated with prolonged viral presence. 21 22

A cohort of 68 patients hospitalized (including intensive care unit [ICU] and non-ICU) 25

in Wuhan Taikang Tongji Hospital and Huoshenshan Hospital were prospectively 26 recruited from February 10 to March 20, 2020. They were all laboratory-confirmed 27 COVID-19 patients according to the 7 th version of 'Pneumonia diagnosis and 28 8 treatment for COVID-19 infection' with specific clinical symptoms and radiological 1 abnormalities and two sequential positive SARS-CoV-2 RNA tests or specific serum 2 IgM and IgG antibodies of SARS-CoV-2 11 . Demographic information, clinical indices, 3 underlying diseases, treatment and outcome data were extracted from electronic 4 medical records using a standardized data collection form. Study was approved by the 5 Ethics Commission of Shanghai East Hospital, China and informed consent was 6 obtained from participants. 7 CURB-65 score was determined on the day of admission according to clinical criteria 8 (confusion; urea >7 mmol/l; respiratory rate≥30/min; either diastolic blood pressure 9 ⩽60 mm Hg or systolic blood pressure <90 mm Hg; age≥65 years) defined by the 10 British Thoracic Society (BTS) 17 . 11

Both nasopharyngeal swab and sputum specimens were collected every 1-2 days after 14 admission for detection of the SARS-CoV-2 RNA using real-time reverse 15 transcription-polymerase chain reaction (rRT-PCR) until two sequential negative 16 results were obtained. Briefly, induced sputum was obtained after inhalation of 10 mL 17 of 3% hypertonic saline through a mask with oxygen at a flow rate of 6L/min for 20 18 mins, if patients did not have sputum; tracheal aspirates sputum was collected through SARS-CoV-2, and those with Ct values of ≥40 or with undetectable results were 27 9 considered negative. We defined the interval between symptom onset and the date of 1 the first SARS-CoV-2 RNA negative result for respiratory samples including both 2 nasopharyngeal swab and sputum specimens as the shedding duration. 3

Serum samples were detected for IgM/IgG antibodies against SARS-CoV-2 using the 5 colloidal gold immunochromatography antibody detection kit (Innovita Biological 6 Technology Co., Ltd., China). Briefly, the serum samples were firstly incubated at 7 56°C for 30 minutes to heat-inactivate viruses, and then added into the sample well of 8 the testing plate. After addition of reaction buffer and incubation for 10-15 minutes at 9 room temperature, testing result could be achieved and interpreted according to the 10 instructions. 11

The measurement data of normal distribution were presented as mean ± standard 13 deviation (SD) and compared by t test or variance analysis. While the measurement 14 data of non-normal distribution were expressed by median (M) and upper and lower 15 quartile spacing (IQN) and compared by Wilcoxon or Kruskal-Wallis Rank Sum Test. 16

The categoric variables were presented as numbers and percentages and were 17 compared by chi-square or Fisher exact test. The analyses of risk factors associated 18 with detecting SARS-CoV-2 RNA in NPS or sputum or both were conducted using 19 one-way ANOVA or the chi-square test. To identify risk factors associated with the 20 duration of SARS-CoV-2 RNA shedding, we used a Cox proportional hazards model 21 that adjusted for baseline covariates. Outcome was defined as time interval from 22 symptom onset to SARS-CoV-2 RNA negativity in both NPS and sputum specimens. 23

For this analysis, we censored patients if they never cleared SARS-CoV-2 RNA or, if 24 they were discharged alive or dead before they had cleared SARS-CoV-2 RNA. 25

Potential variables for analysis of prolonged duration of SARS-CoV-2 RNA shedding 26 were as follows: sex, age, comorbidities, lymphocyte counts, and treatment with 27 steroids. A hazard ratio (HR) of >1 indicated prolonged viral RNA shedding. In 28 multivariable-adjusted Cox regression models, HR was further adjusted for covariates 1 including age and sex. We performed Kaplan-Meier survival analysis to estimate the 2 cumulative SARS-CoV-2 RNA-negativity rate among respiratory specimens and the 3 stratified log-rank test to compare the difference of virus clearance between patients 4 with age <65 years and ≥65 years. Statistical analyses were performed using STATA 5 15 and two-sided p value < 0.05 was considered statistically significant. conventional oxygen support were used in 21 (30.9 %) and 18 (26.5%) patients 1 respectively. Upon admission, the severity of patients was evaluated by CURB-65: 30 2 patients (44.1%) had score 1, 36 patients (52.9%) had score 2, and 2 patients reached 3 score 3. Meanwhile, the overall mortality of all patients was 4.4%. The time interval ranged from 6 days before to 16 days after the NPS turned negative. 18

sputum specimens 20

We then explored the possible factors associated with the yields of NPS and sputum in 21 detecting SARS-CoV-2 RNA respectively. The results showed chronic lung disease 22

(CLD) and systemic steroids use were associated with SARS-CoV-2 RNA detection 23 from sputum and diabetes mellitus was associated with viral RNA detection from 24 NPS or sputum specimens. We futher performed a sensitivity analysis in patients 25 without CLD in order to take into consideration of the possible effect of CLD on the 26 association of systemic steroids with detection of SARS-CoV-2 RNA. There still 27 existed a statistical difference in positive sputum rate between the steoids use group 28 and non-steroids use group (steroids use: 11/17; non-steroids use: 9/39; P=0.003), 1 which was consistent with the previous results. Besides, chronic lung disease was 2 associated with both NPS and sputum positive for SARS-CoV-2 RNA detection. 3 (Table 2) . 4

The median duration of viral shedding from NPS and from sputum specimens was 19 6 days (IQR 14-25 days) and 34 days (IQR 24-40 days), respectively (P<0.001), and by 7 pooling together, the median duration of SARS-CoV-2 RNA shedding from either 8 NPS or sputum specimens was 21 days (IQR, 16-31 days). Of 63 patients with 9

rRT-PCR confirmed SARS-CoV-2 infection, only 4 patients (6.3%) had undetectable 10 virus RNA within 8 days, 18 patients (28.6%) tested negative within 14 days, and 41 11 patients (65.1%) tested negative within 28 days after illness onset (Figure 3) . 12

We further explored SARS-CoV-2 shedding duration and potential risk factors. In a 13 multivariable model, elderly age (≥65 years) was identified as an independent factor 14 associated with the viral shedding time in hospitalized patients ( Table 3) . 15 SARS-CoV-2 RNA clearance was significantly delayed in patients aged ≥65 years 16 compared with those aged <65 years after onset of illness (HR, 1.71 [95%CI, 17 1.12-2.93]; p<0.01; Figure 3B ). 18

We found 2 patients who had recurrent positive detection of SARS-CoV-2 RNA from 21 NPS specimens (Figure 4) after serially negative tests. Case 1 is a 68-year-old woman 22 with a history of diabetes mellitus for 20 years. After 9 consecutive negative NPS 23 tests, SARS-CoV-2 RNA was detected again in NPS at day 29 after illness onset 24 while the SP were tested positive serially for 6 times from day 16 to day 29. Case 2 is 25 a 55-year-old man with hypertension and cardiac disease. From day 9 to day 25 after 26 illness onset, the patient had 11 consecutive negative NPS test and 7 consecutive 27 positive SP tests, and then he had recurrent positive detection of virus RNA in NPS at 28 13 day 25. These two cases continued to receive isolation and surveillance in hospital 1 until NPS test turned negative. When these two cases converted to NPS positive, they 2 remained clinically stable without recurrence of symptoms and substantial changes in 3 laboratory examinations. In the present study, we have found the median duration of SARS-CoV-2 shedding 7 from either NPS or sputum specimens was 21 days and the median duration of viral 8 shedding from sputum was significantly longer than from NPS. Age was identified as 9 an independent risk factor of prolonged viral shedding time. Meanwhile, a 10 combination of NPS and sputum specimens for detecting viral RNA could improve 11 the diagnostic sensitivity. Chronic lung disease and steroids use are associated with 12 the detection of virus RNA from NPS, and DM is associated with the detection of 13 virus RNA from both NPS and sputum specimens. In addition, it was noteworthy that 14 in 9 of 16 hospitalized patients where SARS-CoV-2 RNA was detected both in NPS 15 and sputum specimens, virus RNA could be detected in sputum specimen after the 16 NPS specimen turned negative. 17

Since coronavirus RNA detection is more sensitive than virus isolation by culture, 18 most studies have used viral RNA tests as a potential marker to assess the potential persisted for a median of 20 days in survivors and that is consistent with the findings 23 from our present study 21 . Additionally, we have found that age was an independent 24 factor associated with prolonged SARS-COV-2 RNA shedding. Previously, it has 25 been suggested that increased age was associated with mortality in SARS and MERS 26

and may lead to death in COVID-19 patients 22,23 . One possible reason for this is the 27 age-dependent dysfunction of lymphocyte and the overproduction of type 2 28 14 cytokines 24 . This could further result on slower viral clearance and prolonged 1 shedding time 21 . 2 According to the Chinese guideline for COVD-19 11 , the criteria for discharge were 3 absence of fever for at least 3 days, substantial improvement in both lungs in chest CT, 4 clinical remission of respiratory symptoms, and two throat-swab samples negative for 5 SARS-CoV-2 RNA obtained at least 24 h apart 25 . However, there is growing evidence 6

showing that a certain amount of discharged patients have tested positive during 7 follow-up 9 . In the present study, we describe two patients in detail who had a 8 recurrence of detection of SARS CoV-2 virus RNA from NPS after previously 9

converting to negative testing. The possible reasons for the relapse are multifold. First, 10 COVID-19 is a novel coronaviral infectious disease, so the clinical features and 11 course has not been fully understood. The pathogen of the disease is an RNA 12 beta-coronavirus named SARS-COV-2 and mutation may occur during transmission 13 which could lead to ineffective antibodies produced by the recovered patients. If the 14 discharged patient is re-infected by the mutated virus, the nucleic acid test may be 15 positive again. Negative results may also occur if a patient still has very low levels of 16 viral shedding, but their viral load is below the lower threshold of assay detection. 17

In the present study, we found that viral RNA could be detected in sputum specimen 18 after the NPS specimen turned negative, which was consistent with previous report 19 describing 22 patients with COVID-19 who had positive rRT-PCR results for SARS-20

CoV-2 in the sputum or feces after negative conversion of pharyngeal swabs 26 . We 21 also found that the duration of viral shedding in sputum specimens was longer than 22 that in NPS. These findings may impact a test based clearance discharge criteria given 23 patients with COVID-19 may shed virus longer in their respiratory tracts, with 24 potential implication for prolonged transmission risk. Additionally, although not 25 routinely recommended for initial diagnostic testing for SARS-CoV-2 27 , induced 26 sputum should be considered as an alternative for testing SARS-CoV-2 RNA when 27 individuals are highly suspected of COVID-19 but nasopharyngeal or oropharyngeal 28 consecutively negative. 1

There are still several limitations of the present study. First, the interpretation of our 2 findings might be limited by its small sample size. Second, NPS specimens were 3 obtained by different clinicians and this could have an impact on its detecting 4 sensitivity. Third, lymphocyte subtypes and serum IgM/IgG antibody titers test were 5 not performed. It was therefore not possible to determine the relationship between 6 antiviral response and prolonged SARS-CoV-2 shedding. At last, another limitation is 7 that we detected virus by rRT-PCR instead of by virus isolation by culture. It is 8 becoming more widely accepted that prolonged viral shedding may not indicate 9 infectivity, because rRT-PCR does not distinguish between infectious virus and 10 non-infectious nucleic acid. 28 In spite of this, relative cautious management strategies 11 are still warranted for optimal transmission prevention, especially among vulnerable 12 populations and healthcare staffs. Further studies are needed to determine whether 13 individuals with prolonged positive NPS or sputum are infectious or not. 14 15

In patients hospitalized with COVID-19, the median duration of viral shedding from 17 sputum specimens was significantly longer than from NPS. Elderly age was 18 independently associated with prolonged SARS-CoV-2 shedding in the respiratory 19

specimens. Viral RNA could be detected in sputum specimen after the nasopharyngeal 20 swabs became negative in some patients. These findings may impact a test based 21 clearance discharge criteria given patients with COVID-19 may shed virus longer in 22 lower respiratory tracts, with potential implication for prolonged transmission risk. In 23 addition, more attention should be given to elderly patients who might have prolonged 24 viral shedding period. Besides, more studies are needed to determine whether 25 prolonged viral shedding indicates infectivity of patients. 

Oh 

Clinical Characteristics of Coronavirus Disease 14 2019 in China

Clinical features of patients infected with 2019 16 novel coronavirus in Wuhan

Patients With 2019 Novel Coronavirus-Infected Pneumonia in

Epidemiological and clinical characteristics 21 of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a 22 descriptive study

Shedding in Patients With Avian Influenza A(H7N9) Virus Infection

Influenza A Virus Shedding

Interpreting a covid-19 test result

Chest CT for Typical 31 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

Positive RT-PCR Test Results in Patients Recovered 34

Detection of SARS-CoV-2 in Different Types of 11

Receptor Recognition by the 13

Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long 14

Structural Studies of SARS Coronavirus

Evaluating the accuracy of different 16 respiratory specimens in the laboratory diagnosis and monitoring the viral 17 shedding of 2019-nCoV infections

Positive rate of RT-PCR detection of SARS-CoV-2 19 infection in 4880 cases from one hospital in